by Marcia Schekel
A diagnosis … mesothelioma … a punch to the gut … frozen with fear.
Mine was April 2014: surgical biopsy, pleural mesothelioma (epithelioid), inoperable, stage 4.
What is this strange disease? I ‘google’ meso, lawyers call. Arghhh. Somehow I contact the Meso Foundation, Mary calls. I know I am connected with others with meso. I […]
by Marcia Schekel
Charity Navigator has awarded the Meso Foundation its highest rating, reserved for organizations that exceed industry standards and outperform most charities in their cause. Charity Navigator is the nation’s largest and most-utilized evaluator of charities with the mission to guide intelligent giving.
The Meso Foundation is the only mesothelioma charity to receive a 4-star rating. The […]
As of June 1, Dr. Kiran Turaga, a surgeon from the Medical College of Wisconsin, will be joining Dr. Hedy Kindler and the University of Chicago Medicine’s mesothelioma team.
Dr. Turaga began his career at the Medical College of Wisconsin in 2010. His interest has focused on peritoneal surface malignancies and regional therapies, which includes HIPEC.
On April 26, we had the opportunity to attend Bloomberg Government’s conference on Building the Big Data Economy: Personalized care and cancer treatment in the age of big data. The conference centered around two main topics: the Precision Medicine Initiative (PMI) and the Cancer Moonshot Initiative (CMI).
The event kicked off with a conversation about precision […]
For cancer patients, a diagnosis is generally followed by staging. Among other things, the stage of a cancer tells the patient and physician if the cancer has spread and if it’s metastasized to the lymphatic system or other organs, etc. This information is used to determine the course of treatment (i.e. whether the cancer is […]